The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

AI agents are now being weaponized through prompt injection, exposing why model guardrails are not enough to protect enterprise data. If you can only read one tech story a day, this is it. We use ...

Ranked by Value of all metro-area SBA loans in 2025 Ranked by Total local employees Ranked by Total Closings Wilmington Trust is pleased to welcome Kristen Stevenson as a Senior Wealth Advisor in its… ...